Nifty Pharma Nifty Pharma index of it breaks n sustain above 14560 then one can buy pharma majors.
All frontline pharma stocks can b bought above this .
Cipla, sunpharma, lupin, auropharma, biocon & glenmark.
Pharmastocks
Granules India ReversalThe stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby.
Risk Reward Ratio - 2:1
SL is placed below support zone & the lower trendline. The target is placed based on fundamentals and near all time high.
$XAIR Symmetrical Triangle BreakBeyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
ADMA (ADMA BIOLOGICS INC) BUYHi there. Price is forming a big reversal pattern to change its direction. Also is close to 0 value which is a very good sign. Watch strong price action at the current levels for buy.
Auropharma (aurobindo pharma )1. rising wedge pattern formation
2. and inverted flag pattern
3. a clear short opportunity
MERCK GOOD OPPORTUNITY Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891
Entry on the bullish break of the dynamic trendine or on exceeding the weekly maximum. Excellent operation with a risk / return ratio of 1.20
Do you have Diamond Hands? Check out NXRP's Volatile Reversal...NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily.
Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug.
High risk with potentially high reward: up to a 25% drawdown and a potential 100+% gain leading to a 4:1 risk to reward ratio. With a ~30% short interest this could be a wild ride like GME or AMC.
Risk management by day trading may be possible.
Vertex, a great pharmaceutical at a discounted priceA company with over 10 years of consistent and constant growth, a wide coverage of products already on the market and... despite an excellent quarterly for a news or a trail .. boom .. It drops suddenly ?
In my opinion this is sheer market madness, the sites I use as a reference for fundamental analysis confirm to me what I say, the company always be more than 50% below its fair value.
To confirm my conviction is also Market Miracle the algorithmic advisor, which has provided an entry signal on the stock at the price of 188 usd, also providing a valuable indication ... that is, that the price of the stock is in the area of oversold.
In the immediate I don’t expect a great climb but given the solidity of the company is definitely a low-risk investment that, given the discounted price can also lead to very interesting gains in the medium term ... obviously if the price starts to rise.
So I decided to increase the positions on Vertex Pharmaceuticals $VRTX hoping to be on the side of the market that as you know always has the reason on its side.
This idea is based on a signal generated by the advisor Marketmiracle, down on this page you will find the link to the page of signals of the advisor that you can see for free without any cost or registration
BIOCONIn hourly tf it has made a bullish hidden divergence and in daily its setting up for an AB=CD near 425-430. View would be negated below 398
Bionano Genomics completes head shoulders and then up ?Bionano is a hyper-technological industry that operates at the level of the human genome.
It has developed a platform with an unprecedented ability to detect structural variations in DNA molecules, is active in research for the fight against cancer and other genetic diseases.
It presented excellent results days ago and now a category of big investors has started to direct its capital on it , typical feature in this period where many biotech and pharmaceutical companies seem to receive large inflows of capital ( see related ideas )
The advisor Marketmiracle tells us that thanks to the indicator Mmiracle Viewer decomposes the market to identify the positions on the securities of the various investors.
It generated an input signal on Bionano Genomics at a price of 7.16 usd with a target of 15.08 usd with a potential profit of 110 %.
From the fundamental point of view the company does not shine but it is a characteristic typical of all the companies that operate in the fields in which the investment in search is a necessary and determining part for the own business.
I checked the situation in the chart and it seems that the target can actually be reached after a short accumulation phase that could lead the title to the formation of a bullish head shoulders, the high volatility of the stock could then help to reach such an ambitious target.
Will Bionano Genomics succeed in its intent ? stay tuned....
This idea is based on the signal generated by the Marketmiracle advisor whose link you can find by scrolling at the bottom of this page.
FLAGIt's become flag clear-cut flag and pole pattern it is it to understand and pharma stock and currently as for the situation and perform good so we should consider this as a good pattern
Auropharma looks goodAuropharma looks good, sustaining 1025 levels, it could move 1056 levels in the near term.
Next Pharma stock to SHOOTAlembic Pharma Ready To .... No matter where market will go...alembic Pharma will go up ...tgt 1250 in next three months
Cipla for solid returns The weekend is a good time to scroll through the charts to find some gems for the coming week and for the coming month.
Cipla is one such stock that came on my radar this week, stock had seen a good move from 738 levels to 966 levels, comprising about 35% return in just 4 -5 weeks.
After seeing a remarkable rally, stock decided to correct, and I as a buyer could take advantage of this correction to grab this stock at attractive levels for participating in the new up leg, that may take stock to 1000 and 1100 levels, and that rally is most likely to come, considering the previous strong price action.
The near-term support is at 855-845 levels, that I am expecting the prices would hold and also bounce from it.
The daily chart also provides good support around 870 and chances are there that stock might reverse from here, hence buying can be done at two trenches.
Trade type: Positional
: Pullback Trade
: Support Buying
If you are trading this, you are trading at your own risk, please do your own research as well.
Share the post, if you find it informative and useful.
Apollo Hospital | Inverted head and shoulder w/ flag patternThis stock closely followed the inverted head and should pattern and broke the neckline. The price target today was nearly short of 40 points if compared w/ neck to head distance which is still good. The stock also touched it's near high today.
It will be interesting to see where does stock head this. I am of the opinion that this will show a short term bearish trend till the nearest support.
Genmab opportunitysteamloss in the Genmab stock will likely fuel a new rush.
1) the 2 previous times times RSI has been below 30, it has resulted in strong returns. Will it happen a 3rd time?
2) The current strongly rising RSI will like make sure that the price will move and stay above the short term downward trend.
3) Opportunity for the price to move towards 2557 DKK. Yet be aware of potential strong resistance around 2364 DKK.
4) If this small up trend can offset the short term setback, 50/200 will likely trigger a new golden cross.
Entered long in 2168 DKK
Titan Biotech - target for 215There is good indication of reversal and trend change from 30th March onwards. Two dates are mentioned in the chart.
Target 215 ++ (20% ++ profit from here)
Follow me for more ideas like this.
Glaxo - Elliott takes a stake will this prompt an increase? Bottom of the range looks a good place to buy GSK.
Underperforming though and needs some impetus for share price growth.
AUROBINDOPHARMA All the key levels are mentioned in chart
Disclaimer
I am not sebi registered analyst
My studies are Educational purpose only
Please consult with your Financial advisor before trading or investing
AstraZeneca (AZN) Rare Investment Opportunity!AstraZeneca (AZN), W1: Support line + Bollinger bands + Hammer + Sell off
Liminal BioSciences, a risky play85% below the July peak of last year and 99% below its all-time high.
Orbiting a major support level around $4.
A capital injection began in mid-November that is still not properly reflected in price.
Stochastic at the oversold point and RSI close to touching it.
It could give the surprise of giving a significant bounce to the marked lines.
The risk is that it has been trading at a loss for some time.
"Liminal (Nasdaq: LMNL) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel treatments for patients suffering from diseases that have high unmet medical need, including those related to fibrosis in respiratory, liver and kidney diseases."
